You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 106 No. 11, November 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Experimental Pseudomonas Keratitis Using Collagen Shields Containing Tobramycin

Jeffery A. Hobden; James J. Reidy, MD; Richard J. O'Callaghan, PhD; James M. Hill, PhD; Michael S. Insler, MD; David S. Rootman, MD

Arch Ophthalmol. 1988;106(11):1605-1607.


Abstract

• To study the effectiveness of collagen shields containing tobramycin sulfate in the treatment of Pseudomonas keratitis, rabbits were infected via an intrastromal injection of Pseudomonas aeruginosa and treated 22 hours later with either collagen corneal shields rehydrated in 4% tobramycin and applied to the cornea or 4% tobramycin drops. Bacterial killing was quantitated by culturing corneal homogenates and calculating the number of viable bacteria (colony-forming units) per cornea. Corneas receiving shields rehydrated in 4% tobramycin and applied for four hours demonstrated significantly reduced numbers of bacteria compared with untreated control corneas. The collagen shields were as effective in reducing the number of viable bacteria per cornea as 4% tobramycin drops applied every 30 minutes over a four-hour period. Over a nine-hour treatment period, the addition of four drops of 4% tobramycin to shields in situ was as effective as exchange with a new shield rehydrated in 4% tobramycin. These results suggest that collagen shields rehydrated in a water-soluble antibiotic such as tobramycin may be an effective and convenient mode of therapy for Pseudomonas keratitis.



Author Affiliations

From the Department of Microbiology, Immunology, and Parasitology (Mr Hobden and Drs O'Callaghan and Hill) and the Lions Eye Research Laboratories, LSU Eye Center (Drs Hill, Reidy, Insler, and Rootman), Louisiana State University Medical Center School of Medicine, New Orleans.


Footnotes

Accepted for publication June 20, 1988.

Reprint requests to LSU Eye Center, 2020 Gravier St, Suite B, New Orleans, LA 70112-2234 (Dr Hill).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Collagen Shields Exacerbate Ulceration of Alkali-Burned Rabbit Corneas
Wentworth et al.
Arch Ophthalmol 1993;111:389-392.
ABSTRACT  

Collagen Shield Enhancement of Topical Dexamethasone Penetration
Hwang et al.
Arch Ophthalmol 1989;107:1375-1380.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.